180 Life Sciences Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by 180 Life Sciences Corp. (not Forum Markets Inc.) on June 25, 2025. The filing announces the scheduling of the Company's 2025 Annual Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses solely on corporate governance events and does not contain financial performance data.
Material Changes
There are no material financial changes reported in this filing. The primary event is the Board of Directors' determination to hold the 2025 Annual Meeting on July 24, 2025, subject to change. The record date for shareholders entitled to vote is set as June 30, 2025, also subject to change.
Guidance, Outlook, and Corporate Actions
- Annual Meeting: Scheduled for July 24, 2025. Time and location will be detailed in the definitive proxy statement.
- Shareholder Proposals: Proposals for inclusion in proxy materials (Rule 14a-8) or director nominations must be received by the Corporate Secretary at the Palo Alto, CA office by the close of business on July 7, 2025.
- Compliance: Proposals must comply with SEC rules, Delaware law, and the Company's Bylaws to be considered timely.
Key Facts for Investor Verification
- Verify the definitive proxy statement for the exact time and location of the July 24, 2025 Annual Meeting.
- Confirm the final record date for voting eligibility, as the Company reserves the right to change the June 30, 2025 date.
- Note the strict July 7, 2025 deadline for submitting shareholder proposals or director nominations.
- Confirm the Company's ticker symbols: Common Stock (ATNF) and Warrants (ATNFW) on NASDAQ.